FDA Inspection 992394 — AndersonBrecon, Inc. d.b.a. PCI of Illinois
The FDA completed an inspection of AndersonBrecon, Inc. d.b.a. PCI of Illinois on November 1, 2016 in Rockford, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 1, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockford, IL (United States)